PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.27%
Some net income increase while CRON.TO is negative at -123.24%. John Neff would see a short-term edge over the struggling competitor.
2.30%
Less D&A growth vs. CRON.TO's 12230.06%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
100.00%
Deferred tax of 100.00% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-60.58%
Negative yoy SBC while CRON.TO is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
97.10%
Slight usage while CRON.TO is negative at -130.75%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
100.06%
Inventory growth of 100.06% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
No Data
No Data available this quarter, please select a different quarter.
-18.36%
Both reduce yoy usage, with CRON.TO at -91.59%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-27.42%
Negative yoy while CRON.TO is 100.55%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
38.10%
Some CFO growth while CRON.TO is negative at -305.12%. John Neff would note a short-term liquidity lead over the competitor.
-133.43%
Negative yoy CapEx while CRON.TO is 92.47%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Negative yoy acquisition while CRON.TO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.88%
Growth well above CRON.TO's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-14.40%
We reduce yoy invests while CRON.TO stands at 95.15%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both yoy lines negative, with CRON.TO at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.